KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Non-Current Debt (2016 - 2025)

Precigen (PGEN) has disclosed Non-Current Debt for 11 consecutive years, with $93.2 million as the latest value for Q4 2025.

  • Quarterly Non-Current Debt changed N/A to $93.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $93.2 million through Dec 2025, changed N/A year-over-year, with the annual reading at $93.2 million for FY2025, N/A changed from the prior year.
  • Non-Current Debt for Q4 2025 was $93.2 million at Precigen, down from $198.7 million in the prior quarter.
  • The five-year high for Non-Current Debt was $201.1 million in Q1 2022, with the low at $93.2 million in Q4 2025.
  • Average Non-Current Debt over 3 years is $172.0 million, with a median of $179.8 million recorded in 2021.
  • The sharpest move saw Non-Current Debt decreased 7.72% in 2021, then grew 15.48% in 2022.
  • Over 3 years, Non-Current Debt stood at $179.9 million in 2021, then increased by 10.45% to $198.7 million in 2022, then plummeted by 53.1% to $93.2 million in 2025.
  • According to Business Quant data, Non-Current Debt over the past three periods came in at $93.2 million, $198.7 million, and $201.1 million for Q4 2025, Q2 2022, and Q1 2022 respectively.